Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PPH vs IHE overlap: 43% of top holdings shared

Bottom line

How much do PPH and IHE overlap?

43% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 48.5% of PPH's assets and 73.4% of IHE's. They share a meaningful core but differ in the rest of the portfolio.

IHE holds far more positions (59 vs 26), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

PPHIHE
Weight overlap (top 25)43%
Shared holdings11
Weight in shared holdings48.5%73.4%
Total positions2659
Expense ratio0.36%0.37%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings PPH and IHE have in common

Holding% of PPH% of IHEOverlap
Eli Lilly & Co20.23%22.25%20.23%
Merck & Co Inc9.85%4.55%4.55%
Pfizer Inc4.51%3.96%3.96%
Bristol-Myers Squibb Co4.47%4.37%4.37%
Johnson & Johnson4.35%22.44%4.35%
Zoetis Inc2.10%3.73%2.10%
Viatris Inc1.10%4.22%1.10%
Axsome Therapeutics Inc0.77%2.42%0.77%
Corcept Therapeutics Inc0.50%1.90%0.50%
Elanco Animal Health Inc0.35%2.81%0.35%
Organon & Co0.23%0.81%0.23%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PPH

  1. Novartis AG — 10.63%
  2. Novo Nordisk A/S — 5.37%
  3. AbbVie Inc — 4.57%
  4. Gsk Plc — 4.42%
  5. AstraZeneca PLC — 4.33%
  6. McKesson Corp — 4.12%
  7. Sanofi SA — 4.00%
  8. Cencora Inc — 3.36%
  9. Haleon PLC — 3.09%
  10. Teva Pharmaceutical Industries Ltd — 3.06%
  11. Takeda Pharmaceutical Co Ltd — 2.87%
  12. Jazz Pharmaceuticals PLC — 1.08%
  13. State Street Global Advisors — 0.28%
  14. Bausch Health Cos Inc — 0.10%

Only in IHE

  1. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
  2. Royalty Pharma Plc — 4.34%
  3. Jazz Pharmaceuticals Public Limited Company — 3.45%
  4. Ligand Pharmaceuticals Incorporated — 1.45%
  5. Definium Therapeutics Inc — 1.39%
  6. Liquidia Corp — 1.28%
  7. Indivior Pharmaceuticals, Inc. — 1.14%
  8. Crinetics Pharmaceuticals Inc — 0.90%
  9. Edgewise Therapeutics Inc — 0.70%
  10. Amneal Pharmaceuticals, Inc. — 0.68%
  11. Enliven Therapeutics Inc — 0.63%
  12. Supernus Pharmaceuticals, Inc. — 0.62%
  13. Tarsus Pharmaceuticals Inc — 0.57%
  14. Veradermics Inc — 0.56%

Asset mix

Asset typePPHIHE
Stocks99.5%99.9%
Cash & short-term funds0.3%6.3%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryPPHIHE
US60.8%96.4%
GB11.8%4.3%
CH10.6%—
DK5.4%—
FR4.0%—
IE1.1%3.8%
IL3.1%—
JP2.9%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do PPH and IHE overlap?
About 43% by weight. 11 securities appear in both funds' top 25 holdings; they make up 48.5% of PPH's assets and 73.4% of IHE's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PPH and IHE have in common?
The largest shared holdings are Eli Lilly & Co, Merck & Co Inc, Bristol-Myers Squibb Co, Johnson & Johnson, Pfizer Inc.
Should I own both PPH and IHE?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PPH or IHE?
IHE is broader, with 59 positions versus 26 for PPH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.